Cerebrospinal Fluid Leak Clinical Trial
Official title:
Single-arm, Open-label, Multicenter Study to Evaluate the Safety and Performance of Dura Sealant Patch in Reducing CSF Leakage Following Elective Cranial Surgery
The objective of the study is to clinically assess the safety and performance of the Dura Sealant Patch as a means of reducing intra- as well as post-operative CSF leakage in patients undergoing elective cranial intradural surgery with a dural closure procedure.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04057157 -
Post-market Assessment of Biodesign Dural Repair Grafts
|
||
Withdrawn |
NCT02902133 -
Acetazolamide to Prevent Post Operative CSF Leak
|
Phase 2 | |
Recruiting |
NCT02927782 -
Mobilisation Algorithm After Incidental Durotomy
|
N/A | |
Completed |
NCT02891070 -
Efficacy and Safety of FS VH S/D 500 S-apr (Tisseel) as an Adjunct to Sutured Dural Repair in Cranial Surgery
|
Phase 3 | |
Recruiting |
NCT04490629 -
The Efficacy and Safety of a Latest Dural Substitute
|
N/A | |
Withdrawn |
NCT04351061 -
Acetazolamide for the Prevention of Post Operative CSF Leak
|
Phase 2 | |
Recruiting |
NCT04086550 -
Evaluate the Safety and Efficacy of Dura Sealant Patch in Reducing CSF Leakage Following Elective Cranial Surgery
|
N/A | |
Completed |
NCT02457546 -
The EVICEL® Neurosurgery Phase III Study
|
Phase 3 | |
Completed |
NCT04145544 -
A Prospective, Randomized, Controlled Multi-center Study of ArtiFascia® Dural Repair Patch Compared With Commercially Available Dural Substitutes. To Evaluate the Safety and Effectiveness of ArtiFascia® in Subjects Requiring Dural Repair.
|
N/A | |
Completed |
NCT04124523 -
Perioperative CSF Leak Management - an Opinion Study
|
||
Active, not recruiting |
NCT04923867 -
Suturable DuraGen™ PMCF Study
|
||
Withdrawn |
NCT03181464 -
Sphenopalatine Ganglion Nerve Block for Postdural Puncture Headache in Obstetrics
|
Phase 4 |